800 Shares in Humana Inc. (NYSE:HUM) Acquired by Bay Capital Advisors LLC

Bay Capital Advisors LLC bought a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 800 shares of the insurance provider’s stock, valued at approximately $203,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the 4th quarter worth $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA boosted its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management purchased a new stake in shares of Humana during the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. increased its holdings in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Up 2.1 %

Shares of HUM stock opened at $271.65 on Tuesday. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a market cap of $32.79 billion, a price-to-earnings ratio of 27.30, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a 50 day simple moving average of $271.01 and a 200-day simple moving average of $275.60.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.30%. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Piper Sandler increased their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Finally, Barclays raised their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.